As of the latest Form 4 filed Jul 6, 2026.
What Definitive Healthcare Corp insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 16 most recent filings for DH.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-01 | Coop Kevin Chief Executive Officer | FTax | −37.6K | $0.80 | $30.1K | No | Form 4 ↗ |
| 2026-07-06 | 2026-07-01 | Paris Jonathan Chief Legal Officer | FTax | −30.6K | $0.80 | $24.5K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-04 | Hamood Samuel A Director | AAward | +189K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Stephenson Scott G Director | AAward | +189K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Winters Kathleen A Director | AAward | +189K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Chilukuri Sastry Director | AAward | +189K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Heller Casey Chief Financial Officer | FTax | −164K | $0.99 | $163K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Coop Kevin Chief Executive Officer | FTax | −66.0K | $0.99 | $65.4K | No | Form 4 ↗ |
| 2026-05-05 | 2026-05-01 | Krantz Jason Ronald Director | FTax | −12.2K | $0.99 | $12.0K | No | Form 4 ↗ |
| 2026-05-05 | 2026-05-01 | Heller Casey Chief Financial Officer | FTax | −1.47K | $0.99 | $1.45K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Coop Kevin Chief Executive Officer | FTax | −37.6K | $1.09 | $41.0K | No | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Krantz Jason Ronald Director | FTax | −45.2K | $1.09 | $49.2K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Booth Richard Douglas CHIEF FINANCIAL OFFICER | FTax | −3.62K | $6.97 | $25.2K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Shamsuddin Kate Marie CHIEF STRATEGY OFFICER | FTax | −2.51K | $6.97 | $17.5K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Krantz Jason Ronald INTERIM CEO | FTax | −7.66K | $6.97 | $53.4K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Moschella William Chief Product & Tech Officer | AAward | +298K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also DH’s full analysis or the market-wide insider trading feed. The tabs above jump to DH’s other SEC data.
Source: SEC Form 4 filings for DH, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.